BioNTech SE Sponsored ADR
(NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

104.000

- (-%)
Range 103.448 - 107.470   (3.89%)
Open 103.720
Previous Close 104.000
Bid Price 116.800
Bid Volume 12
Ask Price 116.990
Ask Volume 8
Volume 1,208,994
Value -
Remark
Delayed prices. Updated at 30 Apr 2025 04:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis